ClinConnect ClinConnect Logo
Search / Trial NCT06577727

A Study to Collect Data to Build Artificial Intelligence Derived Algorithms for Estimating Iron Status of Children

Launched by DANONE ASIA PACIFIC HOLDINGS PTE, LTD. · Aug 27, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Algorithm Artificial Intelligence Iron Deficiency Ida Anemia

ClinConnect Summary

This clinical trial is looking to gather information to help create smarter tools that can better estimate iron levels in children. Iron is an essential nutrient, and not having enough can lead to health problems, particularly in young kids. The study is currently recruiting participants, specifically children aged between 6 months and 6 years. To participate, parents must be at least 21 years old, have access to the internet, and be comfortable with their child undergoing a blood test.

If you decide to take part, you and your child will fill out some questionnaires online, which will help researchers gather important data. It's important to note that some children may not be eligible for the study, especially those with certain medical conditions or issues that might affect how their blood can be tested. Overall, this trial aims to improve how we assess iron levels in young children, which can lead to better health outcomes.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Children above 6 months of age and below 6 years of age
  • 2. Written consent from parent(s) or legally acceptable representative(s), who themselves are aged ≥ 21 years old, to consent and comply with the terms and conditions of the study
  • 3. Parent(s) should have access to the internet and a smartphone or tablet to complete study questionnaires
  • 4. Parent(s) should be able to comprehend the content of the study and complete the study questionnaires
  • 5. Parents(s) must be comfortable with their child having blood draws
  • 6. Subject has a Hb level corresponding to a Hb group with open slots for participation
  • Exclusion Criteria:
  • 1. Children with any medical condition that in the opinion of the investigator would not be suitable for enrolment.
  • 2. Children with nail bed obstructions, nail polish, nails discolouration (e.g., leukonychia, melanonychia, bruising, etc.), or scarring of the lips, pigmentations on lips for thyroid dysfunction (e.g., Puettz-jeghers syndrome).
  • 3. Children who are unable to cooperate with study procedures.
  • 4. Employees and/or children/family members or relatives of employees of Danone Global Research \& Innovation Center or the participating sites.

About Danone Asia Pacific Holdings Pte, Ltd.

Danone Asia Pacific Holdings Pte, Ltd. is a leading global health-focused food company dedicated to delivering innovative nutritional solutions that promote health and well-being. As a subsidiary of Danone, a multinational corporation with a strong commitment to sustainability and social responsibility, the company operates in diverse markets across the Asia Pacific region. Danone Asia Pacific Holdings Pte, Ltd. actively engages in clinical trials to evaluate the efficacy and safety of its products, aiming to contribute to scientific research and improve health outcomes for consumers. Through its rigorous research initiatives, the company underscores its dedication to advancing knowledge in nutrition and fostering healthier communities.

Locations

Khon Kaen, , Thailand

Singapore, , Singapore

Patients applied

0 patients applied

Trial Officials

Poh Choo Dr Khoo

Principal Investigator

KK Women's and Children's Hospital

Assoc.Prof. Suchaorn Saengnipanthkul

Principal Investigator

Srinagarind Hospital, Khon Kaen University, Khon Kaen

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported